Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Archive
Global health
Authors
About
Help
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Archive
Global health
Authors
About
Help
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are here
Home
Archive
Volume 12, Issue 4
Gemcitabine-induced haemolytic uraemic syndrome in pancreatic adenocarcinoma
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Responses
Article
metrics
Alerts
PDF
Unexpected outcome (positive or negative) including adverse drug reactions
CASE REPORT
Gemcitabine-induced haemolytic uraemic syndrome in pancreatic adenocarcinoma
Online download statistics by month:
Online download statistics by month: April 2019 to January 2021
Abstract
Full
Pdf
Apr 2019
1115
22
30
May 2019
1082
14
17
Jun 2019
578
2
1
Jul 2019
342
7
1
Aug 2019
121
4
4
Sep 2019
111
3
3
Oct 2019
88
0
0
Nov 2019
60
0
5
Dec 2019
57
3
4
Jan 2020
61
1
1
Feb 2020
27
2
0
Mar 2020
68
1
2
Apr 2020
57
0
0
May 2020
47
3
2
Jun 2020
57
1
1
Jul 2020
29
0
0
Aug 2020
31
3
1
Sep 2020
87
1
1
Oct 2020
30
0
0
Nov 2020
35
2
1
Dec 2020
30
1
1
Jan 2021
9
1
0
Total
4122
71
75
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF